BI 689648
BI 689648 is a novel, highly selective aldosterone synthase inhibitor which can inhibit CYP11B1 and CYP11B2 with IC50s of 310 and 2.1 nM, respectively.
Product Specifications
CAS Number
[1633009-87-6]
UNSPSC
12352005
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/BI_689648.html
Purity
99.20
Solubility
DMSO : 30 mg/mL (ultrasonic; warming)
Smiles
O=C(N1CCCC2=C1N=CC(C3=CC(COC)=CN=C3)=C2)N
Molecular Formula
C16H18N4O2
Molecular Weight
298.34
References & Citations
[1]Weldon SM, et al. Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates. J Pharmacol Exp Ther. 2016 Oct;359 (1) :142-50.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP11
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1148734-01 0.02 mg (E-Coli)
Recombinant Brevibacillus brevis Glycerol kinase (glpK)
Ask
View Details MBS1148734-02 0.02 mg (Yeast)
Recombinant Brevibacillus brevis Glycerol kinase (glpK)
Ask
View Details MBS1148734-03 0.1 mg (E-Coli)
Recombinant Brevibacillus brevis Glycerol kinase (glpK)
Ask
View Details MBS1148734-04 0.1 mg (Yeast)
Recombinant Brevibacillus brevis Glycerol kinase (glpK)
Ask
View Details MBS1148734-05 0.02 mg (Baculovirus)
Recombinant Brevibacillus brevis Glycerol kinase (glpK)
Ask
View Details